Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.7198
-0.0801 (-10.01%)
At close: Jun 9, 2026, 4:00 PM EDT
0.6502
-0.0696 (-9.67%)
After-hours: Jun 9, 2026, 7:55 PM EDT
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $63.54 million as of June 9, 2026. Its market cap has decreased by -2.41% in one year.
Market Cap
63.54M
Enterprise Value
64.71M
1-Year Change
-2.41%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has decreased from $90.21M to $63.54M, a decrease of -29.57%. That is a compound annual growth rate of -9.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 70.61M | -16.73% |
| Dec 31, 2025 | 84.80M | 3.05% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organigram Global | 152.23M |
| Assertio Holdings | 151.41M |
| Cardiol Therapeutics | 121.10M |
| Cumberland Pharmaceuticals | 87.80M |
| BGM Group | 58.85M |
| InterCure | 54.92M |
| SCYNEXIS | 44.19M |
| Talphera | 43.95M |